The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive Tumor Therapy (TTD).
 
Alfredo Carrato
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche; Sanofi
Speakers' Bureau - Amgen; Bayer; Celgene; Merck
Travel, Accommodations, Expenses - Merck; Roche
 
Bartolomeu Massuti Sureda
No Relationships to Disclose
 
Manuel Benavides
Honoraria - Bayer
 
Carmen Guillén Ponce
No Relationships to Disclose
 
Esther Falco
No Relationships to Disclose
 
Pilar Garcia Alfonso
No Relationships to Disclose
 
Margarita Reboredo
No Relationships to Disclose
 
Maria Teresa Cano
No Relationships to Disclose
 
Javier Gallego
No Relationships to Disclose
 
Jose Maria Vieitez de Prado
No Relationships to Disclose
 
Laura Layos
No Relationships to Disclose
 
Antonia Salud
No Relationships to Disclose
 
Vicente Alonso
No Relationships to Disclose
 
Emma Dotor
No Relationships to Disclose
 
Ana Yuste
No Relationships to Disclose
 
Silvia Gil
No Relationships to Disclose
 
Reyes Ferreiro Monteagudo
No Relationships to Disclose
 
Teresa Fernandez Rodriguez
No Relationships to Disclose
 
Enrique Grande
No Relationships to Disclose
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche Pharma AG; Sanofi